Jinxin Fertility Group Limited (1951.HK) HKSE

2.46

-0.04(-1.60%)

Updated at December 24 12:08PM

Currency In HKD

Jinxin Fertility Group Limited

Address

No. 301, North Jingsha Road

Chengdu,

China

Phone

86 40 0042 6868

Sector

Healthcare

Industry

Medical - Care Facilities

Employees

3198

First IPO Date

June 25, 2019

Key Executives

NameTitlePayYear Born
Yang DongChief Executive Officer, Acting Chief Financial Officer & Executive Director492,9331986
Rong LyuCo-CEO & Executive Director3.22M1982
Lihong GengExecutive Director1.59M1969
Yuan LiChief Medical Officer01971
Hongmei DuanChief Operating Officer01981
Man Nar ChungCompany Secretary0N/A

Description

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.